Areas of Focus
- Exploration of epigenetic modifiers in tumor development and progression, discovery of precision therapeutic drugs
Work Experience
- 2017.7-2019.12 - South China University of Technology - Postdoctoral Researcher
- 2020.6-2023.9 - Central South University - Lecturer
- 2023.9-present - Central South University - Associate Professor
Academic Background & Achievements
- 2013-2017: PhD in Science, University of Chinese Academy of Sciences / East China University of Science and Technology
- 2010-2013: Master of Science, Northeast Normal University
- 2006-2010: Bachelor of Science, Northeast Normal University
- Hosted 1 national youth project and 2 provincial projects, received the 'Lotus Tip' talent title in Hunan
Publications
- Targeting C21orf58 is a Novel Treatment Strategy of Hepatocellular Carcinoma by Disrupting the Formation of JAK2/C21orf58/STAT3 Complex, Hao Jiang et al., 2024
- COX6C expression driven by copy amplification of 8q22.2 regulates cell proliferation via mediation of mitosis by ROS-AMPK signaling in lung adenocarcinoma, Hao Jiang et al., 2024
- STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient, Hao Jiang et al., 2023
- Deubiquitinase OTUD3: a double-edged sword in immunity and disease, Hao Jiang et al., 2023
- Immunostimulant nanomodulator boosts antitumor immune response in triple negative breast cancer by synergism of vessel normalization and photothermal therapy, Hao Jiang et al., 2023
- Identification of a CircRNA-miRNA-mRNA Network and Integrated Analysis of Immune Infiltration in Oral Squamous Cell Carcinoma, Hao Jiang et al., 2023
- Fringe family genes and their modulation of Notch signaling in cancer, Hao Jiang et al., 2022
- Upregulated GATA3/miR205-5p Axis Inhibits MFNG Transcription and Reduces the Malignancy of Triple-Negative Breast Cancer, Hao Jiang et al., 2022
- Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis, Hao Jiang et al., 2020
